• Zum Hauptinhalt springen
  • Zum Footer springen

PSY-PGx

  • About
    • Mission
    • Management & Structure
  • Consortium
  • Research
    • Work Packages
    • Careers
    • Publications
    • Clinical Study
  • Patients
    • Local Websites
    • Clinical Study
  • Media
    • Patient Experiences with Pharmacogenetics
    • Press Releases
    • Patient Inclusion
    • X (formerly Twitter)
  • Internal
  • Events
  • Meet the Team
  • News
  1. PSY-PGx
  2. News
  3. Strong PSY-PGx presence at the 2025 ECNP Congress in Amsterdam!
News | 25/09/2025
Congress of the European College of Neuropsychopharmacology (ECNP)

Strong PSY-PGx presence at the 2025 ECNP Congress in Amsterdam!

Five posters to be presented
The PSY-PGx project will be boldly represented at this year's ECNP congress in Amsterdam! If you are attending the congress, do not miss these posters:

Kristian Kleine Schaars (Amsterdam)

EP12-1149: A UK biobank analysis of pharmacogenetics CYP2C19 and CYP2D6 and clinical outcome in mood disorder adults, ePoster session 12 - Transdiagnostic - Date: 14 October 202


Natalia Fares (Barcelona)

PS01-0209 – Pharmacogenetic-guided antidepressant treatment on functional outcome in anxiety and affective disorders: A systematic review and meta-analysis, Date: 11 October 2025 / Time: 12:00 – 13:25


Emma de Brabander (Maastricht)

PS01-0256: Knowledge and Attitudes Regarding Pharmacogenetics of Pharmacists in the Netherlands: A National Online Survey Study, Saturday 11-10-25, 12:00-13


Emma Redaelli (Amsterdam and Milan)

EP12-1145 Impact of pharmacogenetics in psychiatric clinical practice: a case report showing a personalised treatment option, 14 October, 8:00–8:30


Sanah Bedi (Amsterdam)

Title – “Two cases demonstrating the clinical impact of pharmacogenetic-guided treatment.”, ePoster session 8 - Pharmacological interventions and psychedelics, Date: 13 October 2025, Time: 08:00 - 08:30, Location: online

PSY-PGx

A New Intervention for Implementation of Pharmacogenetics in Psychiatry
PSY-PGx Coordinator

Roos van Westrhenen

Psychiatrist & Clinical Pharmacologist (MD, PhD) Parnassia Psychiatric Institute/St. John’s National Academy of Health Sciences, Bangalore, India/King’s College London

Overschiestraat 57
1062 HN Amsterdam, The Netherlands
p;sqguéicbSpziuiuJöcјæ u:ä

Sitemap

About
Consortium Members
Research
Patients
News
Internal


Funding

This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 945151.

Twitter
Editor login
Imprint | Data-Safety